Trial Profile
Comparative reference-controlled investigation of bleeding pattern under treatment with a vaginal delivery system (EVE112) containing a fixed dose combination of etonogestrel and ethinylestradiol A multi-centre, multi-dose, open-label, parallel-group study in healthy females aged 18-40 years and at risk for becoming pregnant
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Ethinylestradiol/etonogestrel (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- Sponsors Evestra
- 06 Feb 2017 New trial record